We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Protein Identified That Maintains Embryonic Stem Cell Pluripotency

By LabMedica International staff writers
Posted on 05 Oct 2014
Print article
Image: Following inhibition of a key protein, these embryonic stem cells underwent differentiation and lost their pluripotency. (Nuclei are in green and nuclei expressing pluripotency factors are in blue and red) (Photo courtesy of Dr. Raffaella Di Micco, New York University Langone Medical Center).
Image: Following inhibition of a key protein, these embryonic stem cells underwent differentiation and lost their pluripotency. (Nuclei are in green and nuclei expressing pluripotency factors are in blue and red) (Photo courtesy of Dr. Raffaella Di Micco, New York University Langone Medical Center).
A protein that is critical in maintaining stem cells in their primitive pluripotentive state was identified and discussed in a recently published paper.

Investigators at the New York University Langone Medical Center (NY, USA) had previously found that the protein BRD4 (bromodomain-containing protein 4) promoted the growth and spread of melanoma by keeping the cancer cells in a relatively immature, stem cell-like state.

In the current study, published in the September 25, 2014, online edition of the journal Cell Reports, the investigators demonstrated in mouse and human embryonic stem cells (ESCs) that BRD4 regulated the capacity for self-renewal and pluripotency. When BRD4 was inhibited chemically or through the use of siRNA, this resulted in induction of epithelial-to-mesenchymal transition (EMT) markers and commitment to the maturation into neural cells while reducing the ESC multi-differentiation capacity in teratoma assays.

BRD4 maintained the transcription of core stem cell genes such as OCT4 and PRDM14 by occupying their super-enhancers (SEs), large clusters of regulatory elements, and recruiting to them Mediator and CDK9, the catalytic subunit of the positive transcription elongation factor b (P-TEFb), to allow Pol-II-dependent productive elongation.

"OCT4 is one of the four factors in the standard "OKSM" cocktail used for turning ordinary cells into induced pluripotent stem cells (iPSCs)," said senior author Dr. Eve Hernando-Monge, associate professor of pathology at the New York University Langone Medical Center. "The new findings suggest that BRD4 enforces stem cell identity from an even higher regulatory level in the cell. In theory we could replace one or more of those OKSM factors with BRD4, or add it to the cocktail to increase reprogramming efficiency—that is something we are working on now."

Related Links:

New York University Langone Medical Center


Gold Member
Turnkey Packaging Solution
HLX
Unit-Dose Packaging solution
HLX
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Urine Collection Container
Urine Monovette

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.